Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Aug 7;99(32):e21634.
doi: 10.1097/MD.0000000000021634.

A novel compound heterozygous mutation in the arginase-1 gene identified in a Chinese patient with argininemia: A case report

Affiliations
Case Reports

A novel compound heterozygous mutation in the arginase-1 gene identified in a Chinese patient with argininemia: A case report

Dongqing Cui et al. Medicine (Baltimore). .

Abstract

Introduction: Arginineemia, also known as arginase deficiency, is a rare autosomal recessive metabolic disease. The diagnosis sometimes may be delayed due to atypical clinical manifestations. Confirmation of arginineemia depends on genetic testing.

Patient concerns: We reported a Chinese male child presenting with hyperargininemia and progressive spastic diplegia, who has a novel compound heterozygous mutation in the arginase-1 (ARG1) gene (c.263-266delAGAA, p.K88Rfs45;c.674T>C,p.L216P), respectively, coming from his mother and father.

Diagnosis: The patient was diagnosed with argininemia with a novel compound homozygous mutation of the ARG1 gene at the age of 12 years.

Interventions: The patient had a low-protein diet (0.8 g/kg/day). Baclofen, eperisone hydrochloride, botulinum toxin, and rehabilitation training were used to improve his spastic diplegia symptoms for 3 months.

Outcomes: The patient's blood arginine was still high after 3 months' low-protein diet. His spastic diplegia symptoms had not aggravated after 3 months' treatment.

Conclusions: Argininemia should be considered in a patient with slowly progressive neurologic manifestations, especially spastic diplegia. This case also suggests that tandem mass spectrometry should be used as an effective tool in the validity of neonatal screening for early diagnosis.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

Figures

Figure 1
Figure 1
Identification of 2 compound heterozygous pathogenic variants within the ARG1 gene in this family. (A) Pedigree of this family. II-1 is the proband with 2 compound heterozygous mutations c.263-266delAGAA p.K88Rfs45 and c.674T>C,p.L216P in ARG1 gene and his father(I-1) and mother (I-2) are definite carriers with variant c.674T>C,p.L216P and c.263-266delAGAA p.K88Rfs45, respectively. But his sister (II-2) has no mutations in the ARG1 gene. (B) Sanger chromatograms (reverse sequence) showing the proband's variants c.263-266delAGAA p.K88Rfs45 and c.674T>C,p.L216P in ARG1 gene (A), his mother's variant only in c.263-266delAGAA p.K88Rfs45 (B), his father's variant only in c.674T>C,p.L216P (C) and no variants in his sister's ARG1 gene.

References

    1. Summar ML, Koelker S, Freedenberg D, et al. The incidence of urea cycle disorders. Mol Genet Metab 2013;110:179–80. - PMC - PubMed
    1. Burrage LC, Jain M, Gandolfo L, et al. Sodium phenylbutyrate decreases plasma branched-chain amino acids in patients with urea cycle disorders. Mol Genet Metab 2014;113:131–5. - PMC - PubMed
    1. Terheggen HG, Lowenthal A, Lavinha F, et al. Familial hyperargininaemia. Arch Dis Child 1975;50:57–62. - PMC - PubMed
    1. Haraguchi Y, Aparicio JM, Takiguchi M, et al. Molecular basis of argininemia. Identification of two discrete frame-shift deletions in the liver-type arginase gene. J Clin Invest 1990;86:347–50. - PMC - PubMed
    1. Lee BH, Jin HY, Kim GH, et al. Argininemia presenting with progressive spastic diplegia. Pediatr Neurol 2011;44:218–20. - PubMed

Publication types